We are happy to announce that our long-term client and trusted partner, Greene Street Pharmaceuticals LLC, strengthened our business relationship today by appointing us as their exclusive API sourcing partner.

The Pennsylvania-based company specializes in #transdermal delivery systems with the vision to make a meaningful impact on patients’ lives. Greene Street utilizes Quinta-Analytica’s API Solution services for multiple projects and is able to leverage the partnership to ensure a high level of continuity and expand their offering beyond the scope of their core service provision.

This is yet another recognition of Quinta’s world-class API Solutions program, which supports partners from all geographies and backgrounds with our robust services – now and into the future!

Additional News

  • 11 September 2025

    Meet us at CPHI 2025

    This October, the global pharmaceutical community will gather in Frankfurt for CPHI 2025. Quinta-Analytica as a member of Conscio Group will be there too – visit us in the Contract Manufacturing Hall 5.1, Stand F1.

  • 8 September 2025

    Quinta-Analytica successfully passed two onsite FDA inspections

    In the first half of 2025, Quinta-Analytica underwent two onsite inspections by the U.S. Food and Drug Administration (FDA).

  • 21 July 2025

    Boosting Bioanalytical Power for our clients

    New ICP-MS Expands Our Capabilities